Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.34 |
| ▸ | CTSV | O60911 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | CMA1 | P23946 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14583893 | 1.00 | CTSL (0.34) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL16300723 | 0.82 | BTK (0.37) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL11936290 | 0.82 | BTK (0.37) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL8225109 | 0.82 | BTK (0.37) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL13689038 | 0.82 | BTK (0.37) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL8278853 | 0.82 | BTK (0.37) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL16316252 | 0.82 | CTSK (0.33) | CTSSCTSKHDAC4HDAC1HDAC6 | |
| SCHEMBL25277749 | 0.81 | CTSV (0.44) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL10138844 | 0.81 | CTSV (0.44) | CTSLCTSVCTSBELANECMA1 | |
| SCHEMBL8271424 | 0.81 | CTSV (0.44) | CTSLCTSVCTSBELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | SCHERING CORPORATION | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042968-A1 | Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease | PRSS1, PRSS3, HPN | CTSL 486/4885CTSV 126/4885CTSB 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.